Gaenzle Christopher L
EVP, CAO & General Counsel at PRA Health Sciences, Inc.; CAO, GC & Sec at INC Research Holdings, Inc.
- Sold, on record
- $18.1M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Jun 17, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PRA Health Sciences, Inc.EVP, CAO & General Counsel
- INC Research Holdings, Inc.CAO, GC & Sec
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INC Research Holdings, Inc.163,356 shares
- PRA Health Sciences, Inc.61,713 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale INC Research Holdings, Inc.UnusualSep 1, 2017 2017
Sold 42,601 shares at $58.67 ($2.5M)
Gaenzle Christopher L, CAO, GC & Sec
Sold 39.7% of holdings ($6.3M position)64,824 shares left5.5x usual sizeFiling
- 2 Form 4 sale INC Research Holdings, Inc.Plan not statedSep 18, 2017 +17 days
Sold 4,682 shares at $54.56 ($255k)
Gaenzle Christopher L, CAO, GC & Sec
Sold 7.7% of holdings ($3.3M position)55,897 shares left0.5x usual sizeFiling
- 3 Form 4 sale INC Research Holdings, Inc.Plan not statedJan 22, 2018 +126 days
Sold 1,470 shares at $41.00 ($60k)
Gaenzle Christopher L, CAO, GC & Sec
Sold 2.7% of holdings ($2.3M position)53,634 shares left0.2x usual sizeFiling
- 4 Form 4 sale PRA Health Sciences, Inc.Plan not statedAug 13, 2020 +934 days
Sold 1,364 shares at $102.88 ($140k)
Gaenzle Christopher L, EVP, CAO & General Counsel
Sold 3.5% of holdings ($4M position)37,636 shares leftFirst sale on recordFiling
- 5 Form 4 sale PRA Health Sciences, Inc.Plan not statedJan 8, 2021 +148 days
Sold 3,136 shares at $130.04 ($408k)
Gaenzle Christopher L, EVP, CAO & General Counsel
Sold 8.3% of holdings ($4.9M position)34,500 shares leftFiling
- 6 Form 4 sale PRA Health Sciences, Inc.Plan not statedJun 1, 2021 +144 days
Sold 850 shares at $170.45 ($145k)
Gaenzle Christopher L, EVP, CAO & General Counsel
Sold 2.3% of holdings ($6.4M position)36,473 shares leftFiling
- 7 Form 4 sale PRA Health Sciences, Inc.UnusualJun 16, 2021 +15 days
Sold 28,866 shares at $167.41 ($4.8M)
Gaenzle Christopher L, EVP, CAO & General Counsel
Sold 45.6% of holdings ($10.6M position)34,500 shares left21.2x usual sizeFiling
- 8 Form 4 sale PRA Health Sciences, Inc.UnusualJun 17, 2021 +1 day
Sold 27,497 shares at $168.67 ($4.6M)
Gaenzle Christopher L, EVP, CAO & General Counsel
Sold 44.4% of holdings ($10.5M position)34,500 shares left12.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2021 | Jun 21, 2021 | PRA Health Sciences, Inc. | EVP, CAO & General Counsel | Form 4 sale | 27,497 | $4.6M | 44.4% | Unusual | SEC |
| Jun 16, 2021 | Jun 17, 2021 | PRA Health Sciences, Inc. | EVP, CAO & General Counsel | Form 4 sale | 28,866 | $4.8M | 45.6% | Unusual | SEC |
| Jun 1, 2021 | Jun 3, 2021 | PRA Health Sciences, Inc. | EVP, CAO & General Counsel | Form 4 sale | 850 | $145k | 2.3% | Plan not stated | SEC |
| Jan 8, 2021 | Jan 11, 2021 | PRA Health Sciences, Inc. | EVP, CAO & General Counsel | Form 4 sale | 3,136 | $408k | 8.3% | Plan not stated | SEC |
| Aug 13, 2020 | Aug 17, 2020 | PRA Health Sciences, Inc. | EVP, CAO & General Counsel | Form 4 sale | 1,364 | $140k | 3.5% | Plan not stated | SEC |
| Jan 22, 2018 | Jan 23, 2018 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 1,470 | $60k | 2.7% | Plan not stated | SEC |
| Sep 18, 2017 | Sep 19, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 4,682 | $255k | 7.7% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 5, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 42,601 | $2.5M | 39.7% | Unusual | SEC |
| Jul 3, 2017 | Jul 5, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 6,873 | $401k | 12.9% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 4, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 4,733 | $216k | 8.9% | Plan not stated | SEC |
| Jan 20, 2017 | Jan 23, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 1,186 | $59k | 2.9% | Plan not stated | SEC |
| Jan 3, 2017 | Jan 4, 2017 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 15,383 | $798k | 27.1% | Unusual | SEC |
| Sep 14, 2016 | Sep 16, 2016 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 4,734 | $204k | 24.6% | Plan not stated | SEC |
| Jul 11, 2016 | Jul 12, 2016 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 21,918 | $881k | 60.2% | Unusual | SEC |
| Jun 15, 2016 | Jun 16, 2016 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 7,702 | $309k | 32.0% | Unusual | SEC |
| Dec 31, 2015 | Jan 4, 2016 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 9,468 | $456k | 56.5% | Unusual | SEC |
| Dec 8, 2015 | Dec 9, 2015 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 25,185 | $1.1M | 77.5% | Unusual | SEC |
| Aug 31, 2015 | Sep 1, 2015 | INC Research Holdings, Inc. | CAO, GC & Sec | Form 4 sale | 17,421 | $717k | 70.5% | Unusual | SEC |